Shrimp anti-lipopolysaccharide factor (SALF), an antimicrobial peptide, inhibits proinflammatory cytokine expressions through the MAPK and NF-κB pathways in LPS-induced HeLa cells

Peptides

Volumn 40, Issue , 2013, Pages 42-48

  Lin, Ming Ching ^a   Pan, Chieh Yu ^b   Hui, Cho Fat ^b   Chen, Jyh Yih ^b   Wu, Jen Leih ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

Author keywords

Antimicrobial peptide; Cervical cancer; Inflammatory response; LPS

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYPEPTIDE ANTIBIOTIC AGENT; SHRIMP ANTI LIPOPOLYSACCHARIDE FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VAGINA EPITHELIUM;

ARTHROPOD PROTEINS; CHEMOKINE CCL2; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-KAPPA B; PEPTIDE FRAGMENTS; PEPTIDES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

DECAPODA (CRUSTACEA);

EID: 84872138624     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.11.010     Document Type: Article

References (38)

1. S.J. Ajizian, B.K. English, and E.A. Meals Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma J Infect Dis 179 1999 939 944
2. S. Akira, and K. Takeda Toll-like receptor signalling Nat Rev Immunol 4 2004 499 511
3. C. Alexander, and E.T. Rietschel Bacterial lipopolysaccharides and innate immunity J Endotoxin Res 7 2001 167 202
4. F. Backhed, and M. Hornef Toll-like receptor 4-mediated signaling by epithelial surfaces: necessity or threat? Microbes Infect 5 2003 951 959
5. A.B. Carter, K.L. Knudtson, M.M. Monick, and G.W. Hunninghake The p38 mitogen-activated protein kinase is required for NF-kappa B-dependent gene expression. The role of TATA-binding protein (TBP) J Biol Chem 274 1999 30858 30863
6. Z.J. Chen, L. Parent, and T. Maniatis Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity Cell 84 1996 853 862
7. J.L. Dean, M. Brook, A.R. Clark, and J. Saklatvala p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes J Biol Chem 274 1999 264 269
8. S.H. Diks, D.J. Richel, and M.P. Peppelenbosch LPS signal transduction: the picture is becoming more complex Curr Top Med Chem 4 2004 1115 1126
9. T.J. Guzik, R. Korbut, and T. Adamek-Guzik Nitric oxide and superoxide in inflammation and immune regulation J Physiol Pharmacol 54 2003 469 487
10. R.Y. Hsu, C.H. Chan, J.D. Spicer, M.C. Rousseau, B. Giannias, and S. Rousseau LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis Cancer Res 71 2011 1989 1998
11. M. Ikebe, Y. Kitaura, M. Nakamura, H. Tanaka, A. Yamasaki, and S. Nagai Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway J Surg Oncol 100 2009 725 731
12. M.N. Kennedy, G.E. Mullen, C.A. Leifer, C. Lee, A. Mazzoni, and K.N. Dileepan A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for Toll-like receptor 4 J Biol Chem 279 2004 34698 34704
13. J.M. Kyriakis, and J. Avruch Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation Physiol Rev 81 2001 807 869
14. B. Li, and Y.L. Zhang Identification of up-regulated genes in human uterine leiomyoma by suppression subtractive hybridization Cell Res 12 2002 215 221
15. M.C. Lin, S.B. Lin, S.C. Lee, C.C. Lin, C.F. Hui, and J.Y. Chen Antimicrobial peptide of an anti-lipopolysaccharide factor modulates of the inflammatory response in RAW264.7 cells Peptides 31 2010 1262 1272
16. L. Liu, Y.H. Li, Y.B. Niu, Y. Sun, Z.J. Guo, and Q. Li An apple oligogalactan prevents against inflammation and carcinogenesis by targeting LPS/TLR4/NF-kappaB pathway in a mouse model of colitis-associated colon cancer Carcinogenesis 31 2010 1822 1832
17. D. Motzkus, S. Schulz-Maronde, A. Heitland, A. Schulz, W.G. Forssmann, and M. Jubner The novel beta-defensin DEFB123 prevents lipopolysaccharide- mediated effects in vitro and in vivo FASEB J 20 2006 1701 1702
18. T. Murakami, S. Yomogida, A. Someya, K. Kuwahara-Arai, H. Tamura, and I. Nagaoka Antibacterial cathelicidin peptide CAP11 suppresses the anandamide production from lipopolysaccharide-stimulated mononuclear phagocytes FEBS Lett 581 2007 140 144
19. T. Murakami, T. Obata, K. Kuwahara-Arai, H. Tamura, K. Hiramatsu, and I. Nagaoka Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in d-galactosamine-sensitized endotoxin shock mice Int Immunol 21 2009 905 912
20. C. Nathan Points of control in inflammation Nature 420 2002 846 852
21. E.M. Palsson-McDermott, and L.A. O'Neill Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4 Immunology 113 2004 153 162
22. C.Y. Pan, T.T. Chao, J.C. Chen, J.Y. Chen, W.C. Liu, and C.H. Lin Shrimp (Penaeus monodon) anti-lipopolysaccharide factor reduces the lethality of Pseudomonas aeruginosa sepsis in mice Int Immunol 7 2007 687 700
23. A.C. Pridmore, G.A. Jarvis, C.M. John, D.L. Jack, S.K. Dower, and R.C. Read Activation of toll-like receptor 2 (TLR2) and TLR4/MD2 by Neisseria is independent of capsule and lipooligosaccharide (LOS) sialylation but varies widely among LOS from different strains Infect Immun 71 2003 3901 3908
24. J.A. Rankin Biological mediators of acute inflammation AACN Clin Issues 15 2004 3 17
25. K.M. Rao, T. Meighan, and L. Bowman Role of mitogen-activated protein kinase activation in the production of inflammatory mediators: differences between primary rat alveolar macrophages and macrophage cell lines J Toxicol Environ Health A 65 2002 757 768
26. J.D. Ren, J.S. Gu, H.F. Gao, P.Y. Xia, and G.X. Xiao A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo Int Immunol 8 2008 775 781
27. J.F. Schindler, J.B. Monahan, and W.G. Smith p38 pathway kinases as anti-inflammatory drug targets J Dent Res 86 2007 800 811
28. S. Sharma, R.D. Yedery, M.S. Patgaonkar, C. Selvaakumar, and K.V. Reddy Antibacterial activity of a synthetic peptide that mimics the LPS binding domain of Indian mud crab, Scylla serrata anti-lipopolysaccharide factor (SsALF) also involved in the modulation of vaginal immune functions through NF-kB signaling Microb Pathog 50 2011 179 191
29. G.T. Spear, E. St John, and M.R. Zariffard Bacterial vaginosis and human immunodeficiency virus infection AIDS Res Ther 4 2007 25
30. M. Szajnik, M.J. Szczepanski, M. Czystowska, E. Elishaev, M. Mandapathil, and E. Nowak-Markwitz TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer Oncogene 28 2009 4353 4363
31. S. Uematsu, and S. Akira Toll-like receptors and innate immunity J Mol Med (Berl) 84 2006 712 725
32. M.G. Vallespi, L.A. Glaria, O. Reyes, H.E. Garay, J. Ferrero, and M.J. Arana A Limulus antilipopolysaccharide factor-derived peptide exhibits a new immunological activity with potential applicability in infectious diseases Clin Diagn Lab Immun 7 2000 669 675
33. X.H. Wang, G.T. Yan, L.H. Wang, X.H. Hao, K. Zhang, and H. Xue The mediating role of cPLA2 in IL-1 beta and IL-6 release in LPS-induced HeLa cells Cell Biochem Funct 22 2004 41 44
34. S. Wesselborg, M.K. Bauer, M. Vogt, M.L. Schmitz, and K. Schulze-Osthoff Activation of transcription factor NF-kappaB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways J Biol Chem 272 1997 12422 12429
35. C. Xie, J. Kang, Z. Li, A.G. Schauss, T.M. Badger, and S. Nagarajan The acai flavonoid velutin is a potent anti-inflammatory agent: blockade of LPS-mediated TNF-alpha and IL-6 production through inhibiting NF-kappaB activation and MAPK pathway J Nutr Biochem 2011
36. Y. Yamamoto, and R.B. Gaynor Role of the NF-kappaB pathway in the pathogenesis of human disease states Curr Mol Med 1 2001 287 296
37. B. Zhang, Z.Y. Liu, Y.Y. Li, Y. Luo, M.L. Liu, and H.Y. Dong Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice Eur J Pharm Sci 44 2011 573 579
38. J. Zhang, L. Wu, and J.M. Qu Inhibited proliferation of human lung fibroblasts by LPS is through IL-6 and IL-8 release Cytokine 54 2011 289 295